193 related articles for article (PubMed ID: 24485529)
1. Five-year malignancy incidence in patients with chronic pruritus: a population-based cohort study aimed at limiting unnecessary screening practices.
Fett N; Haynes K; Propert KJ; Margolis DJ
J Am Acad Dermatol; 2014 Apr; 70(4):651-658. PubMed ID: 24485529
[TBL] [Abstract][Full Text] [Related]
2. Predictors of malignancy development in patients with chronic pruritus.
Fett N; Haynes K; Propert KJ; Margolis DJ
J Dermatol Sci; 2016 May; 82(2):123-8. PubMed ID: 26874971
[TBL] [Abstract][Full Text] [Related]
3. Paraneoplastic itch: an expert position statement from the Special Interest Group (SIG) of the International Forum on the Study of Itch (IFSI).
Weisshaar E; Weiss M; Mettang T; Yosipovitch G; Zylicz Z;
Acta Derm Venereol; 2015 Mar; 95(3):261-5. PubMed ID: 25179683
[TBL] [Abstract][Full Text] [Related]
4. Impact of the timing of hepatitis B virus identification and anti-hepatitis B virus therapy initiation on the risk of adverse liver outcomes for patients receiving cancer therapy.
Hwang JP; Suarez-Almazor ME; Cantor SB; Barbo A; Lin HY; Ahmed S; Chavez-MacGregor M; Donato-Santana C; Eng C; Ferrajoli A; Fisch MJ; McLaughlin P; Simon GR; Rondon G; Shpall EJ; Lok AS
Cancer; 2017 Sep; 123(17):3367-3376. PubMed ID: 28518219
[TBL] [Abstract][Full Text] [Related]
5. Chronic pruritus: a paraneoplastic sign.
Yosipovitch G
Dermatol Ther; 2010; 23(6):590-6. PubMed ID: 21054705
[TBL] [Abstract][Full Text] [Related]
6. Clinical and histopathologic features of paraneoplastic granuloma annulare in association with solid organ malignancies: A case-control study.
Mangold AR; Cumsky HJL; Costello CM; Xie DY; Buras MR; Nelson SA; DiCaudo DJ; Sekulic A; Pittelkow MR
J Am Acad Dermatol; 2018 Nov; 79(5):913-920.e1. PubMed ID: 29920319
[TBL] [Abstract][Full Text] [Related]
7. The age-risk relationship of haematologic malignancies in female patients with systemic lupus erythematosus: a nationwide retrospective cohort study.
Lin YC; Yen JH; Chang SJ; Lin YC
Lupus; 2012 Oct; 21(11):1250-6. PubMed ID: 22740427
[TBL] [Abstract][Full Text] [Related]
8. The risk of cancer in patients with psoriasis: a population-based cohort study in Taiwan.
Chen YJ; Wu CY; Chen TJ; Shen JL; Chu SY; Wang CB; Chang YT
J Am Acad Dermatol; 2011 Jul; 65(1):84-91. PubMed ID: 21458106
[TBL] [Abstract][Full Text] [Related]
9. Risk of Nongenitourinary Cancers in Patients With Spinal Cord Injury: A Population-based Cohort Study.
Kao CH; Sun LM; Chen YS; Lin CL; Liang JA; Kao CH; Weng MW
Medicine (Baltimore); 2016 Jan; 95(2):e2462. PubMed ID: 26765443
[TBL] [Abstract][Full Text] [Related]
10. Drug therapies and the risk of malignancy in Crohn's disease: results from the TREAT™ Registry.
Lichtenstein GR; Feagan BG; Cohen RD; Salzberg BA; Diamond RH; Langholff W; Londhe A; Sandborn WJ
Am J Gastroenterol; 2014 Feb; 109(2):212-23. PubMed ID: 24394749
[TBL] [Abstract][Full Text] [Related]
11. Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.
Weismüller TJ; Trivedi PJ; Bergquist A; Imam M; Lenzen H; Ponsioen CY; Holm K; Gotthardt D; Färkkilä MA; Marschall HU; Thorburn D; Weersma RK; Fevery J; Mueller T; Chazouillères O; Schulze K; Lazaridis KN; Almer S; Pereira SP; Levy C; Mason A; Naess S; Bowlus CL; Floreani A; Halilbasic E; Yimam KK; Milkiewicz P; Beuers U; Huynh DK; Pares A; Manser CN; Dalekos GN; Eksteen B; Invernizzi P; Berg CP; Kirchner GI; Sarrazin C; Zimmer V; Fabris L; Braun F; Marzioni M; Juran BD; Said K; Rupp C; Jokelainen K; Benito de Valle M; Saffioti F; Cheung A; Trauner M; Schramm C; Chapman RW; Karlsen TH; Schrumpf E; Strassburg CP; Manns MP; Lindor KD; Hirschfield GM; Hansen BE; Boberg KM;
Gastroenterology; 2017 Jun; 152(8):1975-1984.e8. PubMed ID: 28274849
[TBL] [Abstract][Full Text] [Related]
12. Ageing, exposure to pollution, and interactions between climate change and local seasons as oxidant conditions predicting incident hematologic malignancy at KINSHASA University clinics, Democratic Republic of CONGO (DRC).
Nkanga MSN; Longo-Mbenza B; Adeniyi OV; Ngwidiwo JB; Katawandja AL; Kazadi PRB; Nzonzila AN
BMC Cancer; 2017 Aug; 17(1):559. PubMed ID: 28835214
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic sphincterotomy and risk of malignancy in the bile ducts, liver, and pancreas.
Strömberg C; Luo J; Enochsson L; Arnelo U; Nilsson M
Clin Gastroenterol Hepatol; 2008 Sep; 6(9):1049-53. PubMed ID: 18585972
[TBL] [Abstract][Full Text] [Related]
14. Risk of Hematologic Cancer in Patients With Undifferentiated Pruritus.
Deng J; Parthasarathy V; Adawi W; Bordeaux Z; Sutaria N; Gami A; Taylor M; Lee KK; Marani M; Brown I; Kambala A; Cornman HL; Alajmi A; Pritchard T; Oladipo OO; Semenov YR; Kwatra SG
JAMA Dermatol; 2022 Jul; 158(7):791-795. PubMed ID: 35612839
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with underlying malignancy in a retrospective cohort of 121 patients with dermatomyositis.
Fardet L; Dupuy A; Gain M; Kettaneh A; Chérin P; Bachelez H; Dubertret L; Lebbe C; Morel P; Rybojad M
Medicine (Baltimore); 2009 Mar; 88(2):91-97. PubMed ID: 19282699
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology, risk of malignancy and patient survival in primary sclerosing cholangitis: a population-based study in Finland.
Barner-Rasmussen N; Pukkala E; Jussila A; Färkkilä M
Scand J Gastroenterol; 2020 Jan; 55(1):74-81. PubMed ID: 31902255
[No Abstract] [Full Text] [Related]
17. Incidence and determinants of chronic pruritus: a population-based cohort study.
Matterne U; Apfelbacher CJ; Vogelgsang L; Loerbroks A; Weisshaar E
Acta Derm Venereol; 2013 Sep; 93(5):532-7. PubMed ID: 23450324
[TBL] [Abstract][Full Text] [Related]
18. Long-term treatment with clozapine and other antipsychotic drugs and the risk of haematological malignancies in people with schizophrenia: a nationwide case-control and cohort study in Finland.
Tiihonen J; Tanskanen A; Bell JS; Dawson JL; Kataja V; Taipale H
Lancet Psychiatry; 2022 May; 9(5):353-362. PubMed ID: 35334224
[TBL] [Abstract][Full Text] [Related]
19. Updates in adult-onset Still disease: Atypical cutaneous manifestations and associations with delayed malignancy.
Sun NZ; Brezinski EA; Berliner J; Haemel A; Connolly MK; Gensler L; McCalmont TH; Shinkai K
J Am Acad Dermatol; 2015 Aug; 73(2):294-303. PubMed ID: 26054431
[TBL] [Abstract][Full Text] [Related]
20. Assessment of pruritus characteristics and impact on burn survivors.
Parnell LK; Nedelec B; Rachelska G; LaSalle L
J Burn Care Res; 2012; 33(3):407-18. PubMed ID: 22210065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
